Abstract:OBJECTIVE:To search the role of Helicobacter pylori (H. pylori) in the progression of gastric carcinogenesis.METHODS:A cohort study was conducted by cluster randomized sampling in Linqu County, a rural area in Shandong Province in northeast China, where the mortality of gastric cancer (GC) is among the highest in the world. In 1989-1990, a gastroscopic examination and serum test was launched among subjects aged 35-64 from 14 randomized villages. Histological diagnosis of gastric mucosa and enzyme-linked immunosorbent assay was used to detect gastric lesions and anti-H. pylori of all participants. A repeated gastroscopic screening was offered to all cohort members in 1994 and 1999 respectively, and all the GC cases, regardless of natural ones or ones by gastroscopy, were registered in the follow-up periods.RESULTS:Fifty-eight cases of GC were identified in 2469 subjects during the 10-year follow-up, 44 were observed in 1603 H. pylori-positive persons (2.74%) and 14 in 866 H. pylori-negative persons (1.62%). The incidence rate of GC in H. pylori-positive is significantly higher than in H. pylori-negative (OR = 1.871, 95% CI: 1.012 - 3.459). There was no significant difference in the progression of gastric carcinogenesis between H. pylori-positive and H. pylori-negative (P > 0.05) among subjects with normal or superficial gastritis (SG) at baseline. In contrast, the significant difference was found in baseline chronic gastritis (CAG) group (P < 0.01), and the GC incidence rate in H. pylori-positive (7/615) is higher than in H. pylori-negative (0/470, P = 0.019). The difference of gastric lesions between H. pylori-positive and H. pylori-negative in subjects with intestinal metaplasia (IM) and dysplasia (DYS) at baseline was statistically significant after a 10-year follow-up (P < 0.05, P < 0.01, respectively), but the GC incidence rate in H. pylori-positive is similar to the rate in H. pylori-negative at the two groups (17/573 and 7/224 in IM group, P = 0.907; 19/368 and 7/122 in DYS group, P = 0.806).CONCLUSIONS:H. pylori is a key risk factor that prompts the transition from chronic atrophic gastritis to advanced precancerous lesions and influences the whole progression of precancerous gastric lesions. H. pylori, perhaps can not cause GC directly, increases the risk of GC in company with other carcinogens. H. pylori seemingly has no important effect on the development of GC when gastric mucosa is normal or superficial gastritis, but this conclusion is required to be further confirmed.

Characteristics of gastric cancers developed more than 10 years after eradication of Helicobacter pylori

Clinicopathologic Features of Early Gastric Cancer after Heli-cobacter pylori Eradication in Japanese Patients: Comparative Study between Early ( 10 Years) Onset

Multicenter study of invasive gastric cancer detected after 10 years of Helicobacter pylori eradication in Japan: Clinical, endoscopic, and histopathologic characteristics

Early-Stage Gastric Cancer Can Be Found in Improved Atrophic Mucosa over Time from Successful Helicobacter pylori Eradication

Characteristics and Early Diagnosis of Gastric Cancer Discovered after Helicobacter pylori Eradication

Helicobacter Pylori Infection Following Endoscopic Resection of Early Gastric Cancer

Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection

Characteristics and Background Mucosa Status of Early Gastric Cancer after Helicobacter Pylori Eradication: A Narrative Review

Long-term endoscopic gastric mucosal changes up to 20 years after Helicobacter pylori eradication therapy

Relationship of Helicobacter Pylori Eradication with Gastric Cancer and Gastric Mucosal Histological Changes: A 10-Year Follow-Up Study

Non-improvement of atrophic gastritis in cases of gastric cancer after successful Helicobacter pylori eradication therapy

[Helicobacter Pylori and the Progression of Gastric Cancer: a 10-Year Cohort Study].

Endoscopic characteristics and high-risk background mucosa factors of early gastric cancer after helicobacter pylori eradication: a single-center retrospective study

Exploration of endoscopic findings and risk factors of early gastric cancer after eradication of Helicobacter pylori

[Changes of Gastric Mucosa Histopathology after Helicobacter Pylori Eradication].

Helicobacter pylori Eradication Does Not Adversely Affect the Clinical Course of Gastric Cancer: A Multicenter Study on Screening Endoscopic Examination in Japan

Analysis of long-term serological and histological changes after eradication of Helicobacter pylori

Endoscopic and Pathological Characteristics of Helicobacter pylori Infection-Negative Early Gastric Cancer

A Case of Small 0-Iic-like Scirrhous Gastric Cancer That Developed 5 Years after Helicobacter Pylori Eradication Placement: A Case Report

Differential Helicobacter pylori Plasticity in the Gastric Niche of Subjects at Increased Gastric Cancer Risk

A Five-Year Follow-Up Study on the Pathological Changes of Gastric Mucosa after H-Pylori Eradication